FdaApplication
BLA 761064
Identifiers
- fda_app_no: BLA761064
Properties
| Property | Value |
|---|---|
| applicant_name | Genentech, Inc. |
| application_type | BLA |
| approval_date | 2017-06-22 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RITUXAN HYCELA | RITUXIMAB; HYALURONIDASE (HUMAN RECOMBINANT) | 1,600MG/13.4ML; 26,800UNITS/13.4ML (120MG/2,000UNITS/ML) | Injection |
| RITUXAN HYCELA | RITUXIMAB; HYALURONIDASE (HUMAN RECOMBINANT) | 1,400MG/11.7ML; 23,400UNITS/11.7ML (120MG/2,000UNITS/ML) | Injection |
2 products